Inogen, Inc. (NASDAQ:INGN) Short Interest Update

Inogen, Inc. (NASDAQ:INGN) was the target of a large drop in short interest during the month of December. As of December 31st, there was short interest totalling 714,200 shares, a drop of 6.2% from the December 15th total of 761,300 shares. Based on an average daily trading volume, of 187,000 shares, the short-interest ratio is currently 3.8 days.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on INGN shares. Needham & Company LLC reaffirmed a “hold” rating on shares of Inogen in a research note on Tuesday, January 14th. StockNews.com cut shares of Inogen from a “buy” rating to a “hold” rating in a report on Friday, December 20th.

Hedge Funds Weigh In On Inogen

Institutional investors have recently modified their holdings of the company. Connor Clark & Lunn Investment Management Ltd. grew its position in Inogen by 312.5% in the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 174,625 shares of the medical technology company’s stock worth $1,694,000 after buying an additional 132,287 shares during the last quarter. JPMorgan Chase & Co. increased its stake in shares of Inogen by 2.7% in the third quarter. JPMorgan Chase & Co. now owns 896,106 shares of the medical technology company’s stock worth $8,692,000 after purchasing an additional 23,891 shares during the period. Barclays PLC raised its stake in Inogen by 72.9% during the 3rd quarter. Barclays PLC now owns 55,508 shares of the medical technology company’s stock valued at $539,000 after purchasing an additional 23,398 shares during the last quarter. B. Riley Wealth Advisors Inc. acquired a new position in shares of Inogen in the second quarter valued at $457,000. Finally, Geode Capital Management LLC grew its stake in shares of Inogen by 1.1% in the 3rd quarter. Geode Capital Management LLC now owns 554,191 shares of the medical technology company’s stock valued at $5,377,000 after purchasing an additional 5,921 shares during the period. Institutional investors own 89.94% of the company’s stock.

Inogen Stock Down 0.5 %

Shares of INGN stock traded down $0.05 during trading hours on Friday, hitting $10.47. 149,232 shares of the company were exchanged, compared to its average volume of 148,305. The firm has a market cap of $249.40 million, a PE ratio of -4.65 and a beta of 1.02. The firm has a fifty day moving average of $9.53 and a 200 day moving average of $9.94. Inogen has a 1 year low of $5.08 and a 1 year high of $13.33.

Inogen Company Profile

Inogen, Inc, a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.